GlucoTrack Inc (GCTK NASDAQ) stock market data APIs
$3.0094
0.28(9.3%)
as of September 4, 2026
Try our APIs with
free plan!
GlucoTrack Inc Financial Data Overview
Price chart is built with
Anychart
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Prev. Close
3.0094
Open
3.2852
High
3.3413
Low
2.9402
52 wk Range
2.95-212.1
Market Cap
2 378 K
P/E Ratio
0.1728
Shares Outstanding
798 K
EPS
-0.76
Beta
0.664
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GlucoTrack Inc data using free add-ons & libraries
Get GlucoTrack Inc Fundamental Data
GlucoTrack Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -15 333 000
- Earnings Per Share: 17
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GlucoTrack Inc News
New
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
RUTHERFORD, N.J., & LA JOLLA, Calif., September 02, 2026--(BUSINESS WIRE)--Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced a collaboration with San Diego Stat...
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances
Medical research ©kaboompics.com Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq's stockholders' equity requirement, with the Nasdaq Hearings Panel granting the company's request for co...
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
RUTHERFORD, N.J. & LA JOLLA, Calif., August 17, 2026--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company's request for continued li...
Top Biotech Gainers: GCTK On The Move, BHC, CORT Boost FY'26 Outlook, NEOG On Watch
(RTTNews) - Today's top gainers included Glucotrack, whose subsidiary announced progress in the development strategy for LT-100, a novel non-narcotic therapy; Nuwellis, following expanded clinical rec...
Get GlucoTrack Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
